Despite the remarkable efficacy of CAR-T cell therapies to treat certain blood cancers, they are expensive thanks partly to complex and lengthy manufacturing procedures. | CAR-T therapies are expensive thanks partly to complex and lengthy manufacturing procedures. Now, scientists have found a potential way that could cut the CAR-T processing time from more than two weeks to a single day by using an implant.
Comments are closed.